Inhibitory Potential of Momordica Charantia Fruit Extract Against Microbial Isolates of Urinary Tract Infection
DOI:
https://doi.org/10.5281/zenodo.20721365Keywords:
Momordica charantia, urinary tract infection, antibacterial property, kirby-bauer, zone of inhibitionAbstract
Urinary Tract Infection (UTI) is a prevalent bacterial infection that carries serious health risks on the present global scale due to its increasing morbidity rates and antibiotic resistance. This study was designed to assess the inhibitory effect of the fruit extract of Momordica charantia (bitter gourd) on bacteria causative agents of UTIs such as Escherichia coli, Klebsiella pneumoniae, and Pseudomonas aeruginosa collected from UTIs patients. This study adopted an experimental research design, which involved using the Kirby-Bauer disc diffusion technique. The concentration of methanol extracts used in this study was 50%, 75%, and 100%. It was observed that there was no inhibition recorded at 50% concentration, while there was a significant zone of inhibition at both 75% and 100% concentrations (p = 0.000 < 0.05). These findings suggest that M. charantia fruit methanol extract possesses inhibitory properties and can serve as a candidate for controlling bacterial growth in UTI cases.
Downloads
References
Abubakar, A. R., & Haque, M. (2020). Preparation of medicinal plants: Basic extraction and fractionation procedures for experimental purposes. Journal of Pharmacy & Bioallied Sciences, 12(1), 1–10. https://doi.org/10.4103/jpbs.JPBS_175_19
Aggarwal, N., Leslie, S., & Lotfollahzadeh, S. (2024). Recurrent urinary tract infections (1st ed., Vol. 2). StatPearls Publishing / National Library of Medicine. https://www.ncbi.nlm.nih.gov/books/NBK557479/
Altun, M., & Orhan, Z. (2023). Determination of phytochemical and antibacterial properties of Momordica charantia seed extracts. Celal Bayar University Journal of Science, 19(4), 309–313.
Apiwansri, J. (2022). Exploring the efficacy of herbal & medicinal plants native to China and Thailand as a complementary & alternative treatment in mitigating Mild-to-Moderate COVID-19 symptoms (Senior thesis, Dominican University of California). Dominican Scholar. https://scholar.dominican.edu/nursing-senior-theses/56/
Ashurst, J. V., & Dawson, A. (2023, July 20). Klebsiella pneumoniae. StatPearls Publishing / NCBI Bookshelf. https://www.ncbi.nlm.nih.gov/books/NBK519004/
Aydin, G., & Kaya, E. (2020). A review: Momordica charantia L.’s biological active components and its potential use in traditional therapies. International Journal of Traditional and Complementary Medicine Research, 1(1), 34–43. https://dergipark.org.tr/tr/download/article-file/1115839
Azimirad, M., Tajbakhsh, M., Yadegar, A., & Zali, M. R. (2021). Recurrent urinary tract infection with antibiotic‐resistant Klebsiella pneumoniae in a patient with Crohn’s disease: A case report. Clinical Case Reports, 9(8), Article e04531. https://doi.org/10.1002/ccr3.4531
Bayyigit, A., Erdem, M. G., Unlu, O., & Demirci, M. (2023). Urinary tract infections caused by Pseudomonas aeruginosa: An 11-year retrospective analysis on antimicrobial resistance. Journal of Infection in Developing Countries, 17(8), 1122–1129. https://go.gale.com/ps/i.do?id=GALE%7CA767509758&sid=sitemap&v=2.1&it=r&p=AONE&sw=w&userGroupName=anon%7Ea711f4d4&aty=open-web-entry
Behzadi, P., Baráth, Z., & Gajdács, M. (2021). It's not easy being green: A narrative review on the microbiology, virulence and therapeutic prospects of multidrug-resistant Pseudomonas aeruginosa. Antibiotics, 10(1), Article 42. https://doi.org/10.3390/antibiotics10010042
Bell, S. (2009). Experimental design. In Elsevier eBooks (pp. 672–675). Elsevier. https://doi.org/10.1016/b978-008044910-4.00431-4
Boopathi, S., Priya, P. S., Haridevamuthu, B., Nayak, S. R. R., Chandrasekar, M., Arockiaraj, J., & Jia, A. (2023). Expanding germ-organ theory: Understanding non-communicable diseases through enterobacterial translocation. Pharmacological Research, 194, Article 106856. https://doi.org/10.1016/j.phrs.2023.106856
Cao, D. (2021). Levofloxacin versus ciprofloxacin in the treatment of urinary tract infections: Evidence-based analysis. Frontiers in Pharmacology, 12, Article 658095. https://doi.org/10.3389/fphar.2021.658095
Cooper, C. J., Krishnamoorthy, G., Wolloscheck, D., Walker, J. K., Rybenkov, V. V., Parks, J. M., & Zgurskaya, H. I. (2018). Molecular properties that define the activities of antibiotics in Escherichia coli and Pseudomonas aeruginosa. ACS Infectious Diseases, 4(8), 1223–1234. https://doi.org/10.1021/acsinfecdis.8b00036
Deguchi, T., Nakane, K., Yasuda, M., Shimizu, T., Monden, K., Arakawa, S., & Matsumoto, T. (2010). Microbiological outcome of complicated urinary tract infections treated with levofloxacin: A pharmacokinetic/pharmacodynamic analysis. International Journal of Antimicrobial Agents, 35(6), 573–577. https://doi.org/10.1016/j.ijantimicag.2010.02.004
E L, D., Gupta, C., Khusro, A., & Salem, A. Z. (2019). Susceptibility of poultry associated bacterial pathogens to Momordica charantia fruits and evaluation of in vitro biological properties. Microbial Pathogenesis, 132, 222–229. https://doi.org/10.1016/j.micpath.2019.05.002
Encyclopedia Britannica. (2024). Germ theory. In Encyclopedia Britannica. https://www.britannica.com/science/germ-theory
Erol, B., Çulpan, M., Çaşkurlu, H., Sari, U., Çağ, Y., Vahaboğlu, H., Ozumut, S. H., Karaman, M. İ., & Caskurlu, T. (2018). Changes in antimicrobial resistance and demographics of UTIs in pediatric patients in a single institution over a 6-year period. Journal of Pediatric Urology, 14(2), 176.e1-176.e5. https://doi.org/10.1016/j.jpurol.2017.12.002
Eyre, H. (2021). Momordica charantia, uses, health benefits, side effects. Medical Health Guide. http://www.medicalhealthguide.com/articles/ampalaya.htm
Finjan, N. M., & Mahmood, A. S. (2022). Gene characterization of extended-spectrum-β-lactamase producing Klebsiella pneumoniae isolates and analysis of interleukin-11 in patients with urinary tract infection. Journal of Pure and Applied Microbiology, 16(2), 1120–1128. https://doi.org/10.22207/JPAM.16.2.39
Frenkel, A. (2022, February 1). Urinary tract infections: An opportunity for antimicrobial stewardship. Clinical Conversations. https://www.thermofisher.com/blog/clinical-conversations/urinary-tract-infections-opportunity-for-antimicrobial-stewardship/
Gayathry, K. S., & John, J. A. (2022). A comprehensive review on bitter gourd (Momordica charantia L.) as a gold mine of functional bioactive components for therapeutic foods. Food Production, Processing and Nutrition, 4(1), Article 28. https://doi.org/10.1186/s43014-022-00089-x
Gaynes, R. P. (2017). The discovery of penicillin—New insights after more than 75 years of clinical use. Emerging Infectious Diseases, 23(5), 849–853. https://doi.org/10.3201/eid2305.161556
Gillespie, S. (1994). Introduction to clinical microbiology. In Elsevier eBooks (pp. 1–11). Elsevier. https://doi.org/10.1016/b978-0-7506-0187-0.50006-7
Gomila, A., Carratalà, J., Eliakim‐Raz, N., Shaw, E., Wiegand, I., Vallejo-Torres, L., Gorostiza, A., Vigo, J., Morris, S., Stoddart, M., Grier, S., Vank, C., Cuperus, N., Van Den Heuvel, L., Vuong, C., MacGowan, A., Leibovici, L., Addy, I., & Pujol, M. (2018). Risk factors and prognosis of complicated urinary tract infections caused by Pseudomonas aeruginosa in hospitalized patients: A retrospective multicenter cohort study. Infection and Drug Resistance, 11, 2571–2581. https://doi.org/10.2147/idr.s185753
Hu, Z., Luo, Y., Wu, Y., Qin, D., Yang, F., Luo, F., & Lin, Q. (2024). Extraction, structures, biological effects and potential mechanisms of Momordica charantia polysaccharides: A review. International Journal of Biological Macromolecules, 269, Article 131498. https://doi.org/10.1016/j.ijbiomac.2024.131498
Hudzicki, J. (2009). Kirby-Bauer disk diffusion susceptibility test protocol. American Society for Microbiology, 15, 55–63.
Hyun, M., Lee, J. Y., Kim, H. A., & Ryu, S. Y. (2019). Comparison of Escherichia coli and Klebsiella pneumoniae acute pyelonephritis in Korean patients. Infection & Chemotherapy, 51(2), 130–138. https://doi.org/10.3947/ic.2019.51.2.130
Imam, T. H. (2024, March 18). Bacterial urinary tract infections. MSD Manual Professional Edition. https://www.msdmanuals.com/professional/genitourinary-disorders/urinary-tract-infections-utis/bacterial-urinary-tract-infections
Jia, S., Shen, M., Zhang, F., & Xie, M. (2017). Recent advances in Momordica charantia: Functional components and biological activities. International Journal of Molecular Sciences, 18(12), Article 2555. https://doi.org/10.3390/ijms18122555
Leelaprakash, G., Dass, S. M., & Kumar, R. A. (2011). In vitro antimicrobial and antioxidant activity of Momordica charantia leaves. Pharmacophore, 2(4), 244–252.
Lin, Z., Yu, J., Liu, S., & Zhu, M. (2022). Prevalence and antibiotic resistance of Klebsiella pneumoniae in a tertiary hospital in Hangzhou, China, 2006–2020. The Journal of International Medical Research, 50(2). https://doi.org/10.1177/03000605221079761
Lyn, I. (2016). Amazing ampalaya. Philippine Council for Health Research and Development (PCHRD-DOST). http://www.pchrd.dost.gov.ph/index.php/databases/2-uncategorised/3307-amazing-ampalaya
Mahmood, M. S. (2019). Momordica charantia L. (bitter gourd) as a candidate for the control of bacterial and fungal growth. Pakistan Journal of Agricultural Sciences, 56(4), 1031–1036. https://doi.org/10.21162/pakjas/19.7684
Matuschek, E., Åhman, J., Webster, C., & Kahlmeter, G. (2018). Antimicrobial susceptibility testing of colistin – evaluation of seven commercial MIC products against standard broth microdilution for Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa, and Acinetobacter spp. Clinical Microbiology and Infection, 24(8), 865–870. https://doi.org/10.1016/j.cmi.2017.11.020
Mlugu, E. M., Mohamedi, J. A., Sangeda, R. Z., & Mwambete, K. D. (2023). Prevalence of urinary tract infection and antimicrobial resistance patterns of uropathogens with biofilm forming capacity among outpatients in Morogoro, Tanzania: A cross-sectional study. BMC Infectious Diseases, 23, Article 660. https://doi.org/10.1186/s12879-023-08641-x
Mount Sinai Health System. (n.d.). Urinary tract infection. https://www.mountsinai.org/health-library/report/urinary-tract-infection
Mwambete, K. D. (2009). The in vitro antimicrobial activity of fruit and leaf crude extracts of Momordica charantia: A Tanzania medicinal plant. African Health Sciences, 9(1), 34–39.
Nair, K. (2021). Experimental research: Meaning and examples of experimental research. Harappa Education. https://harappa.education/harappa-diaries/experimental-research/
Nathalie, L., & Alimsardjono, L. (2019). Inhibitory activity of levofloxacin against MDR Staphylococcus aureus and Pseudomonas aeruginosa clinical isolates. Jurnal Farmasi Dan Ilmu Kefarmasian Indonesia, 6(1), 25–31.
National Academies Press (US). (2004). A theory of germs. In Science, Medicine, and Animals. National Academies Press. https://www.ncbi.nlm.nih.gov/books/NBK24649/
Pang, Z., Raudonis, R., Glick, B. R., Lin, T. J., & Cheng, Z. (2019). Antibiotic resistance in Pseudomonas aeruginosa: Mechanisms and alternative therapeutic strategies. Biotechnology Advances, 37(1), 177–192. https://doi.org/10.1016/j.biotechadv.2018.11.013
Pathkind Labs. (2024, January 19). Everything you need to know about biochemical tests. Pathkind Labs Blog. https://www.pathkindlabs.com/blog/everything-you-need-know-about-biochemical-tests
Podder, V., & Sadiq, N. M. (2024). Levofloxacin. StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK545180/
Reis, A. C., Santos, S. R., Souza, S. C., Saldanha M. G., Pitanga, T. N., & Oliveira, R. R. (2016). Ciprofloxacin resistance pattern among bacteria isolated from patients with community-acquired urinary tract infection. Revista do Instituto de Medicina Tropical de São Paulo, 58, Article 53. https://doi.org/10.1590/S1678-9946201658053
Relich, R. F., Manaloor, J. J., & Christenson, J. C. (2023). Laboratory diagnosis of infection due to bacteria, fungi, parasites, and rickettsiae. In Elsevier eBooks (pp. 1459–1472). Elsevier. https://doi.org/10.1016/b978-0-323-75608-2.00286-x
Savsatli, Y., & Seyis, F. (2019). Determination of suitable solvents for extraction of different fruit parts of bitter melon (Momordica charantia L.). International Journal of Agricultural and Natural Sciences, 9(1), 18–22. https://www.ijans.org/index.php/ijans/article/view/357
Scheld, W. M. (2003). Maintaining fluoroquinolone class efficacy: Review of influencing factors. Emerging Infectious Diseases, 9(1), 1–9. https://doi.org/10.3201/eid0901.020277
Sharma, A., Hooja, S., P, N., & Sharma, R. K. (2021). Prevalence of Escherichia coli and its antibiotic resistance pattern among patients of UTI at a tertiary care hospital. Indian Journal of Medical Microbiology, 39, S18. https://doi.org/10.1016/j.ijmmb.2021.08.063
Smith-Hall, C., Larsen, H. O., & Pouliot, M. (2012). People, plants and health: A conceptual framework for assessing changes in medicinal plant consumption. Journal of Ethnobiology and Ethnomedicine, 8, Article 43. https://doi.org/10.1186/1746-4269-8-43
Sofowora, A., Ogunbodede, E., & Onayade, A. (2013). The role and place of medicinal plants in the strategies for disease prevention. African Journal of Traditional, Complementary and Alternative Medicines, 10(5), 210–229. https://doi.org/10.4314/ajtcam.v10i5.2
Sohail, M., Latif, Z., & Bilal, M. (2014). Antimicrobial activity of various plant extracts against bacterial pathogens isolated from urinary tract infection patients. The Pharmaceutical and Chemical Journal, 1(2), 26–30.
Stein, G. E., Schooley, S., & Nicolau, D. P. (2008). Urinary bactericidal activity of single doses (250, 500, 750 and 1000mg) of levofloxacin against fluoroquinolone-resistant strains of Escherichia coli. International Journal of Antimicrobial Agents, 32(4), 320–325. https://doi.org/10.1016/j.ijantimicag.2008.04.025
Tannupriya, Garg, V. K., & Kapoor, D. (2023). A review on traditional natural compounds and conventional methods for the treatment of UTI. Urine, 5, 13–22. https://doi.org/10.1016/j.urine.2023.04.001
University of Santo Tomas. (2022). Hygiene practices and the perceived severity of urinary tract infections: Leading to help-seeking behavior and management practices of Filipinos. Philippine Health Research Registry. https://registry.healthresearch.ph/index.php/aggregate-report?view=research&layout=details&cid=4766
Venugopal, S. K., Chunchanur, S. K., Panigrahy, R., Tak, V., Yadav, M. K., Chauhan, A., Hs, H., Jayapriya, R., Pundir, S., Bhatt, S., Behera, B., Sumanth, Ambica, R., Chaudhuri, S., & Mohapatra, S. (2024). Changes in antimicrobial resistance of Escherichia coli isolated from community associated urinary tract infection before and during the COVID-19 pandemic in India. Journal of Global Antimicrobial Resistance, 37, 54–61. https://doi.org/10.1016/j.jgar.2024.02.022
Wachtel-Galor, S., & Benzie, I. F. F. (2011). Herbal medicine: An introduction to its history, usage, regulation, current trends, and research needs. In I. F. F. Benzie & S. Wachtel-Galor (Eds.), Herbal Medicine: Biomolecular and Clinical Aspects (2nd ed.). CRC Press / Taylor & Francis. https://www.ncbi.nlm.nih.gov/books/NBK92773/
Wilson, M. G., & Pandey, S. (2024). Pseudomonas aeruginosa. StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK557831/
Yang, X. (2022). Disease burden and long-term trends of urinary tract infections: A worldwide report. Frontiers in Public Health, 12, Article 888205. https://doi.org/10.3389/fpubh.2022.888205
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
How to Cite
